|
|
1.
|
Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy. MedStar authors:
- Chen, Kevin Y
- Peravali, Monica
- Rao, Suman
- Veytsman, Irina
Year: 2022
Citation: - Clinical Lung Cancer. 2022 Apr 29
Institution:
- MedStar Franklin Square Medical Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
All authors: - Chen KY, Geng X, Giaccone G, Joshi I, Kim C, Liu SV, Peravali M, Rao S, Veytsman I
|
|
|
2.
|
Safety and Efficacy of First-Line Pembrolizumab in Black Patients with Metastatic Non-Small Cell Lung Cancer. MedStar authors:
- Chen, Kevin
- Kim, Chul
- Peravali, Monica
- Rao, Suman
- Veytsman, Irina
Year: 2021
Citation: - Oncologist. 26(8):694-700, 2021 08.
Institution:
- MedStar Franklin Square Medical Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department: - Hematology/Oncology Fellowship
Medline publication type:
All authors: - Ahn J, Chen K, Kim C, Liu SV, Peravali M, Rao S, Veytsman I
|
